Have a personal or library account? Click to login
Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach Cover

Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach

Open Access
|Sep 2017

Authors

Barbara Faganel Kotnik

Department of Oncology and Haematology, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia

Janez Jazbec

Department of Oncology and Haematology, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia

Petra Bohanec Grabar

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Cristina Rodriguez-Antona

Hereditary Endocrine Cancer Group Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain

Vita Dolzan

vita.dolzan@mf.uni-lj.si

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
DOI: https://doi.org/10.1515/raon-2017-0040 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 455 - 462
Submitted on: Feb 14, 2017
|
Accepted on: Aug 18, 2017
|
Published on: Sep 18, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Barbara Faganel Kotnik, Janez Jazbec, Petra Bohanec Grabar, Cristina Rodriguez-Antona, Vita Dolzan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.